Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

NCT03971799 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

NETWORK

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

BIOLOGICAL: CD33CART autologous
BIOLOGICAL: CD33CART allogeneic

Sponsor

Center for International Blood and Marrow Transplant Research

Collaborators

[object Object]
[object Object]